Catriona Parker

Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial

Catriona Parker, Rachel Waters, Carly Leighton et al. · The Lancet · 2010 · 331 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Acute Lymphoblastic Leukaemia +11

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

Julie Irving, Amir Enshaei, Catriona Parker et al. · Blood · 2016 · 133 citations · Full text

EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications

Claire Schwab, Sarra Ryan, Lucy Chilton et al. · Blood · 2016 · 132 citations · Full text

Reversing Hypoxic Cell Chemoresistance in Vitro Using Genetic and Small Molecule Approaches Targeting Hypoxia Inducible Factor-1

Louisa M. Brown, Rachel Cowen, Camille Debray et al. · Molecular Pharmacology · 2005 · 122 citations

Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cells<i>in vitro</i>

Roben G. Gieling, Catriona Parker, Lisa A. De Costa et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2012 · 86 citations · Full text

Cell Death, Pathology, Cellular Pharmacology +16